Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.62 |
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
| ▸ | NPY4R | P50391 | 7/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.59 |
| ▸ | NPY1R | P25929 | 5/20 | 0.59 |
| ▸ | APLNR | P35414 | 2/20 | 0.59 |
| ▸ | GLP1R | P43220 | 4/20 | 0.59 |
| ▸ | GCGR | P47871 | 3/20 | 0.59 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.57 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20764557 | 0.94 | APLNR (0.58) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL23273229 | 0.88 | NMBR (0.69) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30429675 | 0.88 | CALCR (0.69) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30168747 | 0.88 | CALCR (0.60) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31182473 | 0.87 | NPY2R (0.70) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30432646 | 0.87 | CALCR (0.67) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31295720 | 0.87 | CALCR (0.65) | CALCRAPLNRGLP1RGCGRRAMP3 | |
| SCHEMBL30658211 | 0.87 | CALCR (0.71) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29410250 | 0.86 | CALCR (0.72) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30432038 | 0.86 | CALCR (0.72) | CALCRNPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11911451-B2 | Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers | ImmuLogix Ltd (US) | 2024-02-27 | — | — | US | disclosed |
| US-20210121546-A1 | COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS | ImmuLogix Ltd (US) | 2021-04-29 | — | — | US | disclosed |